A Prospective, Multicenter, Open, Randomized, Comparative Study to Evaluate the Safety and Efficacy of Ertapenem Versus it's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults

NCT00157898 Phase 4 COMPLETED

This was a prospective, randomized, controlled, open, and multi-center trial conducted to compare the clinical efficacy and safety of ertapenem with it's comparator before or following adequate surgical management of complicated intra-abdominal infection.

Details

Lead sponsor	Merck Sharp & Dohme LLC
Phase	Phase 4
Status	COMPLETED
Enrolment	134
Start date	2004-01
Completion	2004-09

Conditions

• Complicated Intra-abdominal Infection

Interventions

• MK0826; ertapenem sodium
• Comparator: ceftriaxone + metronidazole

Primary outcomes

• Favorable clinical response at 7-14 days after treatment